BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30099516)

  • 1. HLA and KIR Associations of Cervical Neoplasia.
    Bao X; Hanson AL; Madeleine MM; Wang SS; Schwartz SM; Newell F; Pettersson-Kymmer U; Hemminki K; Tiews S; Steinberg W; Rader JS; Castro F; Safaeian M; Franco EL; Coutlée F; Ohlsson C; Cortes A; Marshall M; Mukhopadhyay P; Cremin K; Johnson LG; Garland SM; Tabrizi SN; Wentzensen N; Sitas F; Trimble C; Little J; Cruickshank M; Frazer IH; Hildesheim A; Brown MA; Duncan EL; Sun YP; Leo PJ
    J Infect Dis; 2018 Nov; 218(12):2006-2015. PubMed ID: 30099516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer.
    Martin MP; Borecki IB; Zhang Z; Nguyen L; Ma D; Gao X; Qi Y; Carrington M; Rader JS
    Immunogenetics; 2010 Dec; 62(11-12):761-5. PubMed ID: 20857097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of KIR genes and HLA-C alleles with HPV-related uterine cervical disease in Korean women.
    Song MJ; Lee CW; Kim JH; Lee SJ; Kim CJ; Hur SY; Park TC; Kim TG; Park JS
    Tissue Antigens; 2013 Mar; 81(3):164-70. PubMed ID: 23398510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of HLA-C and KIR alleles in human papillomavirus infection and associated cervical lesions.
    Rizzo R; Gentili V; Rotola A; Bortolotti D; Cassai E; Di Luca D
    Viral Immunol; 2014 Nov; 27(9):468-70. PubMed ID: 25188020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.
    Alomar SY; Alkhuriji A; Trayhyrn P; Alhetheel A; Al-Jurayyan A; Mansour L
    Immunogenetics; 2017 Feb; 69(2):69-76. PubMed ID: 27631728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
    Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
    Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
    Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population.
    Al Omar SY; Mansour L; Dar JA; Alwasel S; Alkhuriji A; Arafah M; Al Obeed O; Christmas S
    Genet Test Mol Biomarkers; 2015 Nov; 19(11):617-22. PubMed ID: 26383988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.
    Chandran V; Bull SB; Pellett FJ; Ayearst R; Pollock RA; Gladman DD
    Rheumatology (Oxford); 2014 Feb; 53(2):233-9. PubMed ID: 24185760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
    Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
    Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
    Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
    Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis.
    Sun HS; Liu DX; Bai YY; Hu NW
    Mod Rheumatol; 2019 May; 29(3):531-537. PubMed ID: 29848119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
    Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.
    Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M
    Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
    Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
    J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.
    Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G
    J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.